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Abstract
Background:  One of the most important factors in the initiation and progression of
atherosclerosis is the default in macrophage cholesterol homeostasis. Many genes and transcription
factors such as Peroxisome Proliferators Activated Receptors (PPARs) and Acyl Coenzyme A:
Cholesterol Acyltransferase1 (ACAT1) are involved in cholesterol homeostasis. Fatty Acids are
important ligands of PPARα and the concentration of them can effect expression of ACAT1. So
this study designed to clarified on the role of these genes and fatty acids on the lipid metabolism in
foam cells.
Methods: This study examined effects of c9, t11-Conjugated Linoleic Acid(c9, t11-CLA), Alpha
Linolenic Acid (LA), Eicosapentaenoic Acid (EPA) on the PPARα and ACAT1 genes expression by
using Real time PCR and cholesterol homeostasis in THP-1 macrophages derived foam cells.
Results:  Incubation of c9, t11-CLA, LA cause a significant reduction in intracellular Total
Cholesterol, Free Cholesterol, cellular and Estrified Cholesterol concentrations (P ≤ 0.05). CLA
and LA had no significant effect on the mRNA levels of ACAT1, but EPA increased ACAT1 mRNA
expression (P = 0.003). Treatment with EPA increased PPARα mRNA levels (P ≤ 0.001), although
CLA, LA had no significant effect on PPARα mRNA expression.
Conclusion:  In conclusion, it seems that different fatty acids have different effects on gene
expression and lipid metabolism and for complete conception study of the genes involved in lipid
metabolism in foam cell all at once maybe is benefit.
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Background
Between factors in the atherosclerosis, macrophages have
the most important role. These cells uptake modified low
density lipoproteins (m-LDL) particles such as oxidized
LDL (ox-LDL) by scavenger receptors, that leads esterified
cholesterol (EC) deposition in the cytoplasm and pro-
mote a local pro-inflammatory response [1]. EC stored in
the cytoplasm is in a equilibrium with free cholesterol
(FC) that can leave the cell. Imbalanced in this equilib-
rium can convert a macrophage to the a foam cell. In the
cholesterol loading macrophages (foam cells), cholesterol
turnover intra foam cells is closely related to expression of
many genes. Alteration in rate of expression these genes
effect the macrophage cholesterol influx and efflux, a very
important factor in the initiation and progression of
atherosclerosis. Between of nuclear receptor families that
can bind fatty acids, only PPAR is completely accepted as
a fatty acid-regulated nuclear receptor. Many studies
showed that Proxisome Proliferators Activator Receptors
(PPARs) represent important regulators of genes involved
in macrophage and foam cholesterol homeostasis [2].
Three PPAR subtypes (α, β, γ, and δ) have been described
that two members of this family, PPAR α and PPAR γ, have
critical role in regulation of glucose and lipid metabolism
[2]. PPARα is expressed in many tissues such as liver [3],
kidney [4], heart and also in cells of the arterial wall, in
monocytes/macrophages [5], smooth muscle cells [6],
and endothelial cells [7,8]. PPARα activates expression of
genes involved in fatty acids catabolism [9], ketone bodies
synthesis [10], insulin effects [11] and lipoprotein assem-
bly [12].
Fatty Acids and Synthetic ligands can bind PPAR subtypes
and activate then [13], so these compounds in the man-
agement and treatment of atherosclerosis can used [14].
Saturated and unsaturated fatty acids of ≥ 14-carbon espe-
cially 18- and 20-carbon fatty acids are likely preferred lig-
ands [15]. Two enzymes directly involved in the
homeostasis of FC and EC. When cellular free cholesterol
level decreased, Cholesteryl Ester Hydrolase(CEH) con-
vert cholesterol esters to free cholesterol and fatty
aids[16]. In contrast to the function of CEH, enzyme
Acylco A: Cholesterol Acyltransferase (ACAT) catalyzed
biosynthesis of EC from free cholesterol and long chain
fatty and located in the rough endoplasmic reticulum
(RER). This change made cholesterol less soluble in the
cytosol and facilitating its storage in cytoplasmic lipid
droplets as EC [16]. Two isofoms of ACAT have been
described. ACAT1 is ubiquitous, while ACAT2 is expressed
primarily in the liver and intestine of humans and ani-
mals. The main function of ACAT1 is to prevent excess FC
within cell and cell membrane; in contrast ACAT2 has a
role in lipoprotein synthesis and secretion in liver and
cholesterol absorption in intestine [17]. The level of
ACAT1 mRNA increased in macrophages compared to
monocytes of the mouse liver in response to a high fat,
high cholesterol diet [18,19]. Some studies have been
showed free fatty acids can regulate ACAT1 gene expres-
sion [20,21]. This experiment attempt defined the role of
fatty acids on the PPARα and ACAT1 gene expression.
Effects of fatty acids on the macrophages and foam cells is
vary complicate. Some studies have shown that n-3 and
CLA fatty acids are potent anti-atherogenic nutrients but
others have been showed the pro-atherogenic potential of
CLA [22]. Thus, it is necessary to elucidate the molecular
basis of the controversial anti-atherogenic potential of
CLA. Therefore study evaluates the role of PPARα, ACAT1
and fatty Acids on the lipid metabolism in foam cells.
Materials and methods
Materials
THP-1 cell lined were obtained from the Iranian branch of
Institute Pasture, Phosphate buffered saline (PBS) tablets
were obtained from Takara, Japan. Cell culture media,
Glutamine, penicillin and streptomycin media supple-
ment, Serum Free Medium (SFM) and fetal bovine serum
(FBS) were obtained from Invitrogen Corporation, Pais-
ley, UK. phorbol 12-myristate13-acetate (PMA), dimethyl
sulfoxide (DMSO), Wy 14643, Sandoz 58-035, linolenic
acid, ecosapantaenoic acid and conjugated linoleic acid
were obtained from Sigma-Aldrich, USA. Reagents and
kits for RNA extraction and reverse transcription were
obtained from Qiagen, USA. SYBER Green PCR Master
Mix Reagent and RT2 qPCR Primeres (ACAT1, PPARα, β-
Actin) purchased from (SuperArray Bioscience Corpota-
tion, USA). All other chemicals were obtained from Sigma
Aldrich, USA.
Cell culture
Human monocytic THP-1 cells were grown in RPMI 1640
medium supplemented with 10% heat inactivated fetal
bovine serum (FBS), streptomycin, amphotricin B,
sodium pyruvate, 2 mM L-glutamine, 50 μM 2-mercap-
toethanol in a humid atmosphere containing 5% CO2 at
37°C. For experiments cells were cultured a 1 × 106 den-
sity into 25 cm2 flasks serum free media(SFM) supple-
mented with 0.25% FBS free albumin.
Isolation and acetylating of LDL
Isolation of LDL (1.035 g/mL<d< 1.065 g/mL) was
achieved after a single ultracentrifugation 40,000 g for 10
h at 4°C in a swinging bucket rotor[23]. Isolated was
acetylated by saturated sodium acetate and acetate anhy-
dride was acetylated[24]. Acetylation of LDL confirmed by
acetate cellulose electrophoresis (data not shown).
Cell differentiation and fatty acid treatment
For differentiation THP-1 to macrophage, THP-1 cells
were washed with serum free RPMI 1640 and resuspendedLipids in Health and Disease 2009, 8:38 http://www.lipidworld.com/content/8/1/38
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in SFM in the presence of 100 ng/ml phorbol 12-myristate
13-acetate (PMA) for 72 h [25].
All fatty acids and synthetic ligands dissolved in
DMSO(the medium final concentration was ≤ 0.1%).
Cells pre-treated with fatty acids and chemical ligands
before cholesterol loading for 24 h and then to induction
foam cell transformation, cells were incubated with 50 μg/
ml Ac-LDL in SFM medium for 48 h[26]. The concentra-
tion of fatty acid and chemical ligands in this experiment
was: 100 μM LA, EPA, CLA, 50 μM Wy14643, 5 μM san-
doz 58-035.
RNA extraction and Real time quantitative RT-PCR 
analysis
Expression levels of RNA transcripts were quantitated by
real-time PCR. Total RNA was extracted from THP-1 cells
using the RNA easy kit (Qiagen, USA). The concentration
of RNA was determined by absorbance at 260 nm in rela-
tion to absorbance at 280 nm. RNA was stored at -70°C
until real-time polymerase chain reaction (PCR) was per-
formed. 1 μg of RNA for real time PCR, reversed tran-
scribed by quantiTect Reverse Transcription Kit (Qiagen,
USA) and according to the manufacturer's protocol.
The Real Time PCR was performed by the SYBER Green
PCR Master Mix Reagent. Direct detection of polymerase
chain reaction (PCR) product was monitored by measur-
ing the increase in fluorescence caused by the binding of
SYBER Green to double-stranded DNA. The cycling
parameters was 95°C for 10 min, 40 cycles at 95°C for 15
s; 60°C for 60 s. The housekeeping β-Actin transcript was
used to normalized for the amount and quality of the
RNAs.
Toxicology assay
The viability of cells that treatment with 100 μM fatty acid,
50 μM Wy 14643 and 5 μM sandoz 58-035 was quantified
spectrophotometrically by the 2, 3-bis (2-methoxy-4-
Nitro-5-sulfophenyl)-S-|(phenylamino)carbonyl|-2-tetra-
zolium hydroxide (XXT) assay (Sigma-Aldrich) as
described by Scudiere et al [27]. THP-1 macrophages were
cultured with or without the fatty acids and pharmacolog-
ical ligands for 36 h in 96-well microplate. After an appro-
priate incubation (37°C, 4 h) with XTT the plates were
mixed and absorbance at 570 nm was measured. Results
were expressed as percentage of cell viability with respect
to control negative absorbance (100% cell viability). XTT
assay showed LA, CLA, EPA and synthetic ligands have no
effect on the cell viability in THP-1 in comparison with
control group (Figure 1).
Cellular cholesterol measurement
Differentiated THP-1 macrophages cultured in SFM and
pre-treated with fatty acids and synthetic ligands for 24 h.
Then cells treated with 50 μg/ml Ac-LDL and incubated in
the presence of fatty acids or others ligands for 48 h. After
this incubation period, cells were washed twice with Phos-
phate Buffer Saline (PBS) and homogenized in 200 μl
hexane-isopropanol (3:2) [28]. The organic phase used
for TC and EC measurement by enzymatic assays (Calbio-
chem, USA). FC was measured as the difference between
TC and EC. Cell were lysed with RIPA buffer (10 mM
sodium phosphate, 150 mM NaCl, 0.5% sodium deoxy-
cholate, 0.1% SDS, 100 mg/ml PMSF, 30 ml/ml aprotinin
and 1 mM sodium orthovanadate, 50 mg/ml Dithiot-
rithol pH 7.4) [29] and cellular proteins measured by
Bradford assay[30]. Results were presented as μg lipids/
mg cellular proteins.
Statistical analysis
All results are presented as means ± S.D. Differences
between the groups were determined by one-way ANOVA,
with Post-Hoc comparison by Tukeymultiple comparison
test. The level of significance for all statistical analyses was
set at P < 0.05. Analysis was performed using SPSS for
Windows software.
Results
Cellular EC, FC in Cholesterol-Loaded Macrophages
To determine the effect of fatty acids and synthetic lig-
ands(Wy14643, Sandoz 50-035) on the cholesterol distri-
bution between FC and EC, THP-1-derived differentiated
macrophages loaded with Ac-LDL (50 μg/mL) for 48
hours. Fatty acids and specific synthetic PPARα ligand
(Wy14643) and ACAT1 ligand (Sandoz 50-035) added 24
Cell viability in the presence of fatty acids and synthetic lig- ands Figure 1
Cell viability in the presence of fatty acids and syn-
thetic ligands. Cell viability was determined by the XTT 
assay and expressed as percentage of absorbance. Data rep-
resent mean +SD of at least three experiments run in tripli-
cates. Data showed the fatty acid and other treatments had 
no significant effect (P = 0.118) on cellular viability.Lipids in Health and Disease 2009, 8:38 http://www.lipidworld.com/content/8/1/38
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hours before cholesterol loading. As presented in figure 2
incubation with fatty acids caused a significant decrease in
intracellular total cholesterol(TC), free cholesterol(FC),
percentage of cellular EC and estrified cholesterol
(EC)concentrations (P = 0.05). All of the fatty acids,
PPARα activation by Wy14643 decreased cellular TC in
foam cells. However inhibition of cholesterol estification
by Sandoz 58-035 had no significant effect on the cellular
FC (Figure 2).
Molecular markers of macrophage cholesterol metabolism
Figure 3 and figure 4 show the effect of LA, CLA and EPA
on PPARα and ACAT1 mRNA expression, in comparison
with the PPARα agonist WY-14643 and ACAT1 inhibitor
Sandoz58-035.
ACAT1 mRNA expression was significantly increased by
100 μM EPA (P = 0.003) but c9, t11-CLA, LA and Sandoz
58-035 had no significant effect on the ACAT1 mRNA
expression compared to foam cells treated with DMSO
(control). Treatment with Wy14643 and EPA increased
PPARα mRNA levels (P = 0.05, P = 0.05 respectively),
although CLA and LA had no significant effect on PPARα
mRNA expression (figure 4).
Discussion
Foam cell macrophages are involved in all stages of
atherosclerosis, also human THP-1 monocyte-macro-
phages previously established as a valuable model for
studying the lipid metabolism in human macrophages
and have been used to study the effects of natural and
pharmacological ligands involved in lipid metabolism of
macrophage.
Increased uptake of modified LDL, via the scavenger
receptors caused the accumulation of unesterified, or free,
cholesterol (FC) and esterified cholesterol (EC) by such
foam cell macrophages [31].
Pervious studies have shown that n-3 and CLA fatty acids
can inhibit the progression and promoting process of
atherosclerosis and so are potent anti-atherogenic nutri-
ents in vivo. In contrast Mondy, et al showed the pro-
atherogenic potential of CLA in C57BL/6 mice [22]. Thus,
it is necessary to elucidate the molecular basis of the con-
troversial anti-atherogenic potential of CLA. Therefore the
present study focused on the effects of the individual n-3
fatty acids and CLA on molecular markers of cholesterol
homeostasis in THP-1 derived macrophages as the most
important component of the process of atherosclerosis.
This study investigated the effects of CLA, LA and EPA fatty
acids on the intracellular lipid distribution and ACAT1
and PPARα gene expression in THP-1 derived foam cells.
Incubation of THP-1 cells with the different fatty acids
Fatty acids decreases Intracellular total cholesterol (TC), free  cholesterol (FC) and esterified cholesterol (EC) levels in  THP-1 derived foam cells Figure 2
Fatty acids decreases Intracellular total cholesterol 
(TC), free cholesterol (FC) and esterified cholesterol 
(EC) levels in THP-1 derived foam cells. THP-1 derived 
macrophages were cholesterol-loaded with Ac-LDL (50 μg/
mL) for 48 hours. Wy14643 (50 μmol/L) and Sandoz58-035 
(5 μM) was added 24 hours before cholesterol-loading and 
thereafter every 24 hours. TC and FC were enzymatically 
determined and CE were calculated as the difference 
between TC and FC. Results are the mean ± SD of triplicate 
determinations, representative of 3 independent experi-
ments. Statistically significant differences between treatments 
are indicated by one-way ANOVA followed by Tukey multi-
comparison test. Compared with controls all treatments 
were significant (p ≤ 0.05).
The effects of fatty acids (100 μM), Wy14643 (50 μmol/L)  and Sandoz58-035 (5 μM) on mRNA levels of ACAT1 in  THP-1 macrophages derived foam cells Figure 3
The effects of fatty acids (100 μM), Wy14643 (50 
μmol/L) and Sandoz58-035 (5 μM) on mRNA levels of 
ACAT1 in THP-1 macrophages derived foam cells. 
Cells were treated for 48 h with fatty acids and pharmacolog-
ical compounds. mRNA levels analyzed by cyber green pro-
cedures. The values normalized to β-actin. All results 
represent means ± SD from triplicate determinations, repre-
sentative of 3 independent experiments compared with con-
trol. Significant differences between treatments are indicated 
by one-way ANOVA followed by Tukey multicomparison 
test. *P ≤ 0.05.Lipids in Health and Disease 2009, 8:38 http://www.lipidworld.com/content/8/1/38
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and pharmacological showed that intracellular TC, EC, FC
and percentage of EC reduced. However Sandoz 58-035
hadn't significant effect on the intracellular FC. Theses
data confirm the result obtained by Weldon et al [25] and
Chinetti et al [26]. These effects explained by enhanced
foam cell cholesterol efflux by increasing the availability
of FC for efflux through the ABCA1 and inhibition ACAT1
pathways. Because these fatty acids can effect LXR and
SREBP pathways, further works are required to determine
the roles of them in lipid metabolism of foam cells.
One of the most important changes in foam cell forma-
tion and so initiation and progress of atherosclerosis is
accumulation of lipid droplet in macrophages. Many
genes and factors are involved id lipid accumulation in
macrophage, PPARα and ACAT1 have key role in this phe-
nomenon. One important group of ligands of these fac-
tors are fatty acids [25,32]. Many studies showed that
differentiation of THP-1 cells into macrophages produced
a 2-4-fold increase in ACAT1 expression [32], but some
studies reported no increased in ACAT1 mRNA levels in
THP-1 cells [33] and others showed that fatty acid deriva-
tives reduced levels of ACAT1 expression [23].
Seo et al and others researchers suggested despite of in fact
FFAs can alter ACAT1 mRNA levels in a cell-specific man-
ner; these fatty acids may affect ACAT1 mRNA stability
that leads to various levels of ACAT1 mRNA expression.
Furthermore, differential ACAT1 regulation by different
FFAs could modify storage and distribution of cholesterol
in cell [20]. In current study we found that incubation
THP-1 derived foam cells with EPA can increase expres-
sion of ACAT1 but CLA and LA didn't significant effect.
Another important gene in lipid metabolism in foam cells
is PPARα. PPARα is an important lipid-activated tran-
scription factor that has many roles in regulation genes
involved in lipid and glucose metabolism and inflamma-
tion processes. PPARα is expressed in many types of
human cells, such as macrophages as well as in atheroscle-
rotic plaques macrophages. In macrophages, PPARα regu-
lates the balance between free cholesterol and cholesteryl
esters in THP-1 derived foam cells [25].
Activation of PPARα by natural or synthetic ligands can
induce expression of enzymes such as CPT-1 (carnitine
palmitoyltransferase 1), a key enzyme in mitochondrial
fatty acid catabolism, and so reduced availability of fatty
acids as substrate for ACAT1[26] which can lead to reduc-
tion of intracellular TC and EC[26,34]. But it is likely that
the stimulation of cholesterol efflux to the plasma mem-
brane by other factors such as genes regulated by LXR
results in a reduced intracellular cholesterol as substrate
for ACAT1, thus leading to a reduction in the intracellular
TC and EC content[35].
Our study showed Wy14643 and EPA increased the levels
of PPARα mRNA but CLA and LA didn't effect on the
PPARα gene expression. Many experiments showed die-
tary fatty acids did not induce significant changes PPARα
gene expression in THP-1 derived macrophages and foam
cells and other tissue [25,36-38]. But some studies found
that high polyunsaturated fatty acid diet can increased
mRNA levels of PPARα [39].
In current study all fatty acids compare with macrophages
increased levels of PPARα mRNA (data didn't present) but
compare with foam cells only EPA increased its levels (fig-
ure 5), however LA and CLA didn't significant effect. This
can showed lipid metabolism in foam cells is different
from macrophages and interaction and integration
between ligands and others factors in two type's cells are
not similar.
Conclusion
In conclusion it seems that different fatty acids are ligands
that have variable affinity for transcription factors and
others factors. These ligands have independent effect on
the lipid metabolism in foam cells. In the other side coor-
dination between genes involved in foam cell lipid metab-
olism is very complicated and this is can explain the
different results obtained by various researchers.
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